2m 2m 2m 2m 2m 2m 2m
Provectus Biopha (PVCT)
OTC
$0.05$0.00 (0.00%)
Price as of Oct 02, 2026- $45.7MMarket Cap
- -28.14%1-Year Change
- BiotechnologyIndustry
Provectus Biopha (PVCT)
$0.05$0.00 (0.00%)
PVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.05 | ||
Change | $0.00 (0.00%) | ||
Open | $0.05 | ||
High | $0.05 | ||
Low | $0.05 | ||
Previous Close | $0.05 | ||
Volume | 15,072 | ||
30-Day Average Volume | 90,320 | ||
1-Week Change | -0.18% | ||
1-Month Change | -7.17% | ||
1-Year Change | -28.14% | ||
3-Year Change | -33.74% | ||
5-Year Change | 2.64% | ||
Fundamentals | |||
Shares Outstanding | 419.5M | ||
Total Assets | $1.7M | ||
Market Cap | $45.7M | ||
Enterprise Value | $54.5M | ||
Period: QTR TTM FY | |||
Revenue | $69,733.00 | ||
Net Income | -$775,839.00 | ||
Free Cash Flow | -$768,874.00 | ||
EBIT | -$714,315.00 | ||
EBITDA | -$712,085.00 | ||
Net Working Capital | -$7.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -76 | ||
Enterprise Value/Revenue | 781 | ||
P/B | -6 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -59 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||